Your browser doesn't support javascript.
loading
Systematic review and meta-analysis of the efficacy and safety of novel monoclonal antibodies for treatment of relapsed/refractory multiple myeloma.
Zhang, Tiantian; Wang, Sen; Lin, Tengfei; Xie, Jingmei; Zhao, Lina; Liang, Zhuoru; Li, Yangqiu; Jiang, Jie.
Afiliación
  • Zhang T; College of Pharmacy, Jinan University, Guangzhou 510632, People's Republic of China.
  • Wang S; College of Pharmacy, Jinan University, Guangzhou 510632, People's Republic of China.
  • Lin T; College of Food Science & Nutritional Engineering, China Agricultural University, Beijing 100083, People's Republic of China.
  • Xie J; College of Pharmacy, Jinan University, Guangzhou 510632, People's Republic of China.
  • Zhao L; College of Pharmacy, Jinan University, Guangzhou 510632, People's Republic of China.
  • Liang Z; College of Pharmacy, Jinan University, Guangzhou 510632, People's Republic of China.
  • Li Y; Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou 510632, People's Republic of China.
  • Jiang J; Institute of Hematology, School of Medicine, Jinan University, Guangzhou 510632, People's Republic of China.
Oncotarget ; 8(20): 34001-34017, 2017 May 16.
Article en En | MEDLINE | ID: mdl-28454113

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Anticuerpos Monoclonales / Mieloma Múltiple Tipo de estudio: Etiology_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Anticuerpos Monoclonales / Mieloma Múltiple Tipo de estudio: Etiology_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article